Rab38 (50 to 58) peptide vaccine, Montanide ISA-51 adjuvanted (University of Heidelberg)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRab38 (50 to 58) peptide vaccine, Montanide ISA-51 adjuvanted (University of Heidelberg)
Drug Alias NameNY-MEL-1 (50 to 58) peptide/Montanide ISA-51 vaccineRab38 (50 to 58) peptide/Montanide ISA-51 vaccine
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Synthetic peptide vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Heidelberg
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Heidelberg
Active IndicationsN/A
Inactive IndicationsMelanoma

Other Information

ATC CodeN/A
Related LinksN/A